OAS1 and prostate adenocarcinoma: In addition, high OAS1 expression was associated with poor DFS (disease-free survival), including LGG (P=0.0049), LUAD (P=0.019), PRAD (Prostate adenocarcinoma) (P=0.027), and UVM (P=0.0087) (Figure 5B).